Lb Pharmaceuticals (LBRX) Current Leases (2024 - 2026)

Lb Pharmaceuticals' Current Leases history runs 3 years deep, the most recent figure standing at $730000.0 for Q1 2026.

• On a quarterly basis, Current Leases changed N/A year-over-year to $730000.0 in Q1 2026; TTM through Mar 2026 was $730000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $730000.0, up 49.9% from the prior year.
• Current Leases steadied at $730000.0 in Q1 2026 per LBRX's latest filing, from $730000.0 in the prior quarter.
• Across five years, Current Leases topped out at $730000.0 in Q3 2025 and bottomed at $487000.0 in Q4 2024.
• The 3-year median for Current Leases is $730000.0 (2025), against an average of $669250.0.
• Biggest YoY gain for Current Leases was 49.9% in 2025; the steepest drop was 49.9% in 2025.
• Year by year, Current Leases stood at $487000.0 in 2024, then surged by 49.9% to $730000.0 in 2025, then changed by 0.0% to $730000.0 in 2026.
• Per Business Quant, the three latest LBRX Current Leases figures stand at $730000.0 (Q1 2026), $730000.0 (Q4 2025), and $730000.0 (Q3 2025).